tradingkey.logo

IM Cannabis Corp

IMCC
查看详细走势图
1.280USD
-0.020-1.54%
收盘 02/02, 16:00美东报价延迟15分钟
6.72M总市值
亏损市盈率 TTM

IM Cannabis Corp

1.280
-0.020-1.54%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.54%

5天

-6.57%

1月

-14.09%

6月

-49.41%

今年开始到现在

-7.91%

1年

-41.01%

查看详细走势图

TradingKey IM Cannabis Corp股票评分

单位: USD 更新时间: 2026-02-02

操作建议

IM Cannabis Corp当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在食品与药房零售行业排名28/30位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价0.00。近一个月,市场表现较差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

IM Cannabis Corp评分

相关信息

行业排名
28 / 30
全市场排名
464 / 4529
所属行业
食品与药房零售

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

IM Cannabis Corp亮点

亮点风险
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
业绩增长期
公司处于发展阶段,最新年度总收入37.56M美元
估值低估
公司最新PE估值-1.48,处于3年历史低位
机构加仓
最新机构持股964.07K股,环比增加38.56%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值11.43K

分析师目标

根据 0 位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

IM Cannabis Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

IM Cannabis Corp简介

IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
公司代码IMCC
公司IM Cannabis Corp
CEOFisher (Eyal)
网址https://imcannabis.com/
KeyAI